e-learning
resources
Stockholm 2002
Monday 16.09.2002
COPD - Drug therapy 2
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Inhaled budesonide in the management of chronic obstructive pulmonary diseases
I. M. Laptseva, E. A. Laptseva, V. V. Borshchevsky, G. Gurevich, O. Kalechits (Minsk, Belarus)
Source:
Annual Congress 2002 - COPD - Drug therapy 2
Session:
COPD - Drug therapy 2
Session type:
Thematic Poster Session
Number:
1584
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
I. M. Laptseva, E. A. Laptseva, V. V. Borshchevsky, G. Gurevich, O. Kalechits (Minsk, Belarus). Inhaled budesonide in the management of chronic obstructive pulmonary diseases. Eur Respir J 2002; 20: Suppl. 38, 1584
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Inhaled corticosteroids and survival in chronic obstructive pulmonary disease
Source: Eur Respir J 2003; 21: 202-203
Year: 2003
Maintenance therapy with budesonide and formoterol in chronic obstructive pulmonary disease
Source: Eur Respir J 2004; 24: 1075
Year: 2004
Tiotropium in the management of chronic obstructive pulmonary disease
Source: Eur Respir J 2002; 19: 205-206
Year: 2002
Mechanism by which inhaled bronchodilators prevent exacerbations in chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Asthma and COPD drugs: efficacy, safety and pharmacoeconomics
Year: 2013
Inhaled corticosteroids and hospitalisation due to exacerbation of COPD
Source: Eur Respir J 2003; 22: 286-289
Year: 2003
Role of inhaled antioxidants in chronic obstructive pulmonary disease
Source: Eur Respir J 2005; 26: Suppl. 49, 717s
Year: 2005
Clinical effectiveness of nebulized budesonide in the treatment of acute asthma and exacerbations of chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2001; 18: Suppl. 33, 146s
Year: 2001
Bronchodilators in chronic obstructive pulmonary disease
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=266
Year: 2006
The efficacy and safety of inhaled fluimucil-antibiotic-IT in the treatment of exacerbations of COPD and chronic bronchitis with bronchiectasis
Source: Annual Congress 2013 –COPD diagnosis
Year: 2013
Effects of inhaled Iloprost on hemodynamics in chronic obstructive pulmonary disease
Source: Eur Respir J 2002; 20: Suppl. 38, 27s
Year: 2002
Alveolar absorption and systemic bioactivity of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2004; 24: Suppl. 48, 13s
Year: 2004
Inhaled corticosteroids and survival in chronic obstructive pulmonary disease: does the dose matter?
Source: Eur Respir J 2003; 21: 260-266
Year: 2003
Audit of inhaled corticosteroid prescription in chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2010 - COPD: management
Year: 2010
Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease
Source: Eur Respir J 2003; 21: 74-81
Year: 2003
Effect of systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease
Source: Eur Respir J 2006; 28: Suppl. 50, 624s
Year: 2006
The role of nebulised budesonide in the treatment of exacerbations of COPD
Source: Eur Respir J 2007; 29: 660-667
Year: 2007
Effects of inhaled corticosteroids on airway inflammations of different types in patients with chronic obstructive pulmonary disease or asthma in stable phase
Source: Annual Congress 2009 - Aspects of clinical asthma
Year: 2009
What is the optimal treatment strategy for chronic obstructive pulmonary disease exacerbations?
Source: Eur Respir J 2002; 19: 928-935
Year: 2002
Bifunctional drugs for the treatment of asthma and chronic obstructive pulmonary disease
Source: Eur Respir J 2014; 44: 475-482
Year: 2014
The effect of short-acting beta-two-agonist on pulmonary rehabilitation in chronic obstructive pulmonary disease
Source: Annual Congress 2009 - Pulmonary rehabilitation: extending the scope and benefit of rehabilitation for patients with chronic respiratory disease
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept